Clinical trial
Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active…
NCT00405275 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00405275 |
|---|---|
| Title | Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy |
| Official title | CSP #551 - Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy |
| Acronym | RACAT |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Canadian Institutes of Health Research (CIHR) Rheumatoid Arthritis Investigational Network (RAIN) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Etanercept, methotrexate, Sulfasalazine, Hydroxychloroquine, Placebo, triple, etanercept |
| Enrollment | 353 |
| Start date | Jul 1, 2007 |
| Primary completion | Dec 1, 2011 |
| Completion | May 1, 2012 |
| First posted | Nov 30, 2006 |
| Last update posted | Dec 3, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: